Menopause Clinical Trials

This study is to compare the efficacy of study drug, Enobosarm, administered once daily to that of placebo by evaluating the number of subject reported stress incontinence episodes per day.

Are you a woman experiencing menopause? If so you may be experiencing one or more of the unpleasant symptoms that come with this experience. These are the symptoms of menopause that pharmaceutical companies are trying to find treatments for. Horizons Clinical Research Center, LLC often conducts studies for these new ...

A Study to Evaluate the Efficacy and Safety of Ospemifene in Patients with Moderate to Severe Vaginal Dryness, a Symptom of Vulvo-vaginal Atrophy (VVA) due to Menopause.

Twelve week study of an estrogen vaginal suppository, six visits, to assess its impact on vaginal dryness and pain in menopausal women.

Vaginal atrophy, also called (Vaginal Dryness/Irritation/Painful Intercourse), is thinning, drying and inflammation of the vaginal walls due to your body having less estrogen. Vaginal atrophy occurs most often after menopause. For many women, vaginal atrophy makes intercourse painful — and if intercourse hurts, your interest in sex will naturally decrease. ...

Currently we have the following studies: Birth Control/ Contraceptive Vaginal Atrophy Pain During Intercourse Dysplasia Endometriosis Pap Smear Mammogram Bone Density Osteoporosis Nocturia Uterine Fibroids Uterine Bleeding Post Menopausal Studies HPV STD Hot Flashes

Diablo Clinical Research is conducting a clinical research study to evaluate an investigational medication in postmenopausal women to see its effect on cholesterol. You may qualify for the study if you are: A woman Post menopausal In good general health Not using hormone therapy Qualified participants may receive at no ...

We are looking for postmenopausal women who experience vaginal dryness or pain to participate in a research study that compares an investigational vaginal cream to an already marketed vaginal cream.

Introduction The daily application of estrogen in the vagina can improve the hydrogen potential (pH), vaginal dryness, burning sensation, dyspareunia, and urinary symptoms. Dyspareunia is highly prevalent after menopause as well as in women after gynecological and breast cancer treatment. However, prescription of topical estrogen therapy (THT) to these women ...

Menopause in MS. Multiple sclerosis (MS) affects 3 times more women than men, and before age 50 in about 90% cases, i.e. prior to menopause. There is broad evidence for hormonal regulation of MS in animal models and in clinical cohorts. Around menopause, many clinical patients report symptom worsening associated ...